Search research articles
Contact Us
Filters
Showing results (321-330 of 483) with videos related to
Page
of 49
Sort By:
Blood Advances
|
June 30, 2026
Validation of the newly introduced Deauville Score 5a in patients treated for advanced-stage classic Hodgkin Lymphoma
Simon Leiders, Dominic Ufton, Helen Kaul, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2008
Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy
Peter Dubsky, Paul Sevelda, Raimund Jakesz, et al.
Breast (Edinburgh, Scotland)
|
February 22, 2025
Validation of the CTS5 in four prospective, multicenter, randomized ABCSG trials
Kerstin Wimmer, Dominik Hlauschek, Marija Balic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 20, 2013
ABVD in older patients with early-stage Hodgkin lymphoma treated within the German Hodgkin Study Group HD10 and HD11 trials
Boris Böll, Helen Görgen, Michael Fuchs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2018
Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group
Stephanie Sasse, Helen Goergen, Annette Plütschow, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 5, 2021
Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis
Jakob M Riedl, Florian Posch, Lena Horvath, et al.
The Lancet. Infectious Diseases
|
September 17, 2021
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
Florence Ader, Maude Bouscambert-Duchamp, Maya Hites, et al.
Breast Cancer Research and Treatment
|
January 25, 2024
Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
Kerstin Wimmer, Dominik Hlauschek, Marija Balic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 24, 2020
Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study Group
Stefanie Kreissl, Horst Müller, Helen Goergen, et al.
Leukemia & Lymphoma
|
August 20, 2021
Tafasitamab combined with idelalisib or venetoclax in patients with CLL previously treated with a BTK inhibitor
Philipp Bernhard Staber, Wojciech Jurczak, Richard Greil, et al.
Page
of 49
Search research articles
Search
Showing results (321-330 of 483) with videos related to
Sort By:
Page
of 49
Blood Advances
|
June 30, 2026
Validation of the newly introduced Deauville Score 5a in patients treated for advanced-stage classic Hodgkin Lymphoma
Simon Leiders, Dominic Ufton, Helen Kaul, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2008
Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy
Peter Dubsky, Paul Sevelda, Raimund Jakesz, et al.
Breast (Edinburgh, Scotland)
|
February 22, 2025
Validation of the CTS5 in four prospective, multicenter, randomized ABCSG trials
Kerstin Wimmer, Dominik Hlauschek, Marija Balic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 20, 2013
ABVD in older patients with early-stage Hodgkin lymphoma treated within the German Hodgkin Study Group HD10 and HD11 trials
Boris Böll, Helen Görgen, Michael Fuchs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2018
Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group
Stephanie Sasse, Helen Goergen, Annette Plütschow, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 5, 2021
Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis
Jakob M Riedl, Florian Posch, Lena Horvath, et al.
The Lancet. Infectious Diseases
|
September 17, 2021
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
Florence Ader, Maude Bouscambert-Duchamp, Maya Hites, et al.
Breast Cancer Research and Treatment
|
January 25, 2024
Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
Kerstin Wimmer, Dominik Hlauschek, Marija Balic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 24, 2020
Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study Group
Stefanie Kreissl, Horst Müller, Helen Goergen, et al.
Leukemia & Lymphoma
|
August 20, 2021
Tafasitamab combined with idelalisib or venetoclax in patients with CLL previously treated with a BTK inhibitor
Philipp Bernhard Staber, Wojciech Jurczak, Richard Greil, et al.
Page
of 49